AVE Science & Technology Co Ltd (688067) - Total Liabilities

Latest as of September 2025: CN¥93.09 Million CNY ≈ $13.62 Million USD

Based on the latest financial reports, AVE Science & Technology Co Ltd (688067) has total liabilities worth CN¥93.09 Million CNY (≈ $13.62 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check AVE Science & Technology Co Ltd asset resilience ratio to evaluate the company's liquid asset resilience ratio.

AVE Science & Technology Co Ltd - Total Liabilities Trend (2012–2024)

This chart illustrates how AVE Science & Technology Co Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see AVE Science & Technology Co Ltd total assets.

AVE Science & Technology Co Ltd Competitors by Total Liabilities

The table below lists competitors of AVE Science & Technology Co Ltd ranked by their total liabilities.

Company Country Total Liabilities
Nu Skin Enterprises Inc
NYSE:NUS
USA $578.79 Million
Asure Software Inc
NASDAQ:ASUR
USA $280.12 Million
Hyundai Cement
KO:006390
Korea ₩469.22 Billion
Asia Cement
KO:002030
Korea ₩1.26 Trillion
Astral Resources NL
AU:AAR
Australia AU$4.92 Million
Warriedar Resources Ltd
AU:WA8
Australia AU$16.84 Million
Easy Trip Planners Limited
NSE:EASEMYTRIP
India Rs4.04 Billion

Liability Composition Analysis (2012–2024)

This chart breaks down AVE Science & Technology Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See AVE Science & Technology Co Ltd (688067) balance sheet quality index to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 5.05 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.18 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.15 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how AVE Science & Technology Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for AVE Science & Technology Co Ltd (2012–2024)

The table below shows the annual total liabilities of AVE Science & Technology Co Ltd from 2012 to 2024.

Year Total Liabilities Change
2024-12-31 CN¥65.15 Million
≈ $9.53 Million
-2.53%
2023-12-31 CN¥66.85 Million
≈ $9.78 Million
-10.31%
2022-12-31 CN¥74.53 Million
≈ $10.91 Million
+6.43%
2021-12-31 CN¥70.03 Million
≈ $10.25 Million
+17.01%
2020-12-31 CN¥59.85 Million
≈ $8.76 Million
+33.19%
2019-12-31 CN¥44.94 Million
≈ $6.58 Million
+11.24%
2018-12-31 CN¥40.40 Million
≈ $5.91 Million
+18.35%
2017-12-31 CN¥34.13 Million
≈ $4.99 Million
+1.78%
2016-12-31 CN¥33.54 Million
≈ $4.91 Million
+76.59%
2015-12-31 CN¥18.99 Million
≈ $2.78 Million
-16.14%
2014-12-31 CN¥22.65 Million
≈ $3.31 Million
+13.20%
2013-12-31 CN¥20.01 Million
≈ $2.93 Million
+6.85%
2012-12-31 CN¥18.72 Million
≈ $2.74 Million
--

About AVE Science & Technology Co Ltd

SHG:688067 China Medical Instruments & Supplies
Market Cap
$235.83 Million
CN¥1.61 Billion CNY
Market Cap Rank
#16032 Global
#4619 in China
Share Price
CN¥23.70
Change (1 day)
+1.72%
52-Week Range
CN¥18.15 - CN¥29.63
All Time High
CN¥37.29
About

AVE Science&Technology CO.,LTD researches, develops, manufactures, markets, and services medical devices, biological reagents, remote medical diagnosis network, computer software, automatic control devices, and medical auxiliary equipment China, Europe, the United States, Asia, Africa, and internationally. The company offers urine formed elements analyzer and related reagents, automatic urine ana… Read more